EDUCATION

• 9/78-9/83 Ph.D. in Pharmaceutics & Pharmaceutical Chemistry, The Ohio State University - GPA 3.88. Ph.D. Thesis on ADME including metabolite synthesis and C14 tissue distribution of Anticancer NCI contact Nucleosides under Professor Lou Malspeis.
• in Pharmacy, B.S.9/74-6/78 National Taiwan University

EXPERIENCE

• 6/2014 - 2/2019 Chairman of Board and Chief Executive Officer (CEO), Savior Lifetec Corp.
• 9/2012 - 6/2014 Founding President and Board member of RH Biopharmaceuticals, Inc.
• 1/2010 - 7/2012 Founding President/CSO/Board member, TWi Biotech and TWi Pharma Inc.
• 1/1985- 1/2010  Pfizer Co, Pearl River, NY 10965 (previously Wyeth Research/American Cyanamid/Lederle) In the 25-year tenure, she was promoted through the ranks: Global Head, Senior Director, Director, Department head, Group Leader, Senior Scientist, and served in a variety of early and late stage Pharmaceutical Development functions,

AWARDS

1. Wyeth Chairman of the Board Key Talent Award, a 2003-2007 four year retention stock grant and a large number of Team awards. As the Winner of Wyeth President Award as featured in the 2002 Annual Report cited “M. Sherry Ku, Ph.D., developed novel formulations that overcame significant bioavailability issues for three new clinical leads and several discovery compounds targeting a diverse range of diseases. By creating formulations that allowed the drugs to reach their therapeutic targets, Dr. Ku helped these important compounds move forward in the development process”.
2. She served PhRMA as the human PK prediction team leader (2006-2010). Sherry is an elected USP expert (2010-2014). She was also elected as the board member of NJ pharmaceutical discussion group (2009) and serve as Vice President. She is the current Chair of AAPS PPB section (elected 2010 as Chair elect, 2011 Vice Chair, 2012 Chair).
3. She serves on USP Expert Councils (2010-2015)
4. She served AAPS as the Chair of Physical Pharmacy and Biopharmaceutics (2011-2012) and was featured in AAPS magazine as Member Spotlight in 2012.

PUBLICATIONS AND PATENTS 

63 publications/presentations and 42 published patents and a large number of active invention disclosures (list available upon request)